Glaukos Corporation (GKOS)
USD 145.14
(-0.83%)
USD 145.14
(-0.83%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.78 USD | -33.01% |
| 2022 | -2.09 USD | -95.33% |
| 2021 | -1.07 USD | 60.37% |
| 2020 | -2.70 USD | -758.54% |
| 2019 | 0.41 USD | 210.81% |
| 2018 | -0.37 USD | -13603.7% |
| 2017 | -0.00 USD | -101.93% |
| 2016 | 0.14 USD | 106.57% |
| 2015 | -2.13 USD | -334.69% |
| 2014 | -0.49 USD | 3.92% |
| 2013 | -0.51 USD | 94.76% |
| 2012 | -9.73 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.82 USD | -9.33% |
| 2024 Q2 | -1.00 USD | -21.95% |
| 2024 Q3 | -0.39 USD | 61.0% |
| 2023 Q3 | -0.63 USD | 7.35% |
| 2023 Q2 | -0.68 USD | 5.56% |
| 2023 FY | - USD | -33.01% |
| 2023 Q4 | -0.75 USD | -19.05% |
| 2023 Q1 | -0.72 USD | -9.09% |
| 2022 Q3 | -0.58 USD | 39.58% |
| 2022 Q4 | -0.66 USD | -13.79% |
| 2022 FY | - USD | -95.33% |
| 2022 Q1 | 0.11 USD | 123.4% |
| 2022 Q2 | -0.96 USD | -972.73% |
| 2021 Q2 | -0.38 USD | -5.56% |
| 2021 Q4 | -0.47 USD | -461.54% |
| 2021 Q3 | 0.13 USD | 134.21% |
| 2021 FY | - USD | 60.37% |
| 2021 Q1 | -0.36 USD | -50.0% |
| 2020 Q1 | -1.24 USD | -234.78% |
| 2020 Q2 | -0.90 USD | 27.42% |
| 2020 Q3 | -0.35 USD | 61.11% |
| 2020 Q4 | -0.24 USD | 31.43% |
| 2020 FY | - USD | -758.54% |
| 2019 Q4 | 0.92 USD | 348.65% |
| 2019 FY | - USD | 210.81% |
| 2019 Q3 | -0.37 USD | -117.65% |
| 2019 Q2 | -0.17 USD | -358.22% |
| 2019 Q1 | -0.04 USD | -174.2% |
| 2018 Q4 | 0.05 USD | 126.32% |
| 2018 FY | - USD | -13603.7% |
| 2018 Q2 | -0.15 USD | -87.5% |
| 2018 Q1 | -0.08 USD | -366.67% |
| 2018 Q3 | -0.19 USD | -26.67% |
| 2017 Q4 | 0.03 USD | -25.0% |
| 2017 FY | - USD | -101.93% |
| 2017 Q1 | 0.03 USD | 650.0% |
| 2017 Q2 | -0.10 USD | -433.33% |
| 2017 Q3 | 0.04 USD | 140.0% |
| 2016 FY | - USD | 106.57% |
| 2016 Q2 | 0.07 USD | 133.33% |
| 2016 Q3 | 0.03 USD | -57.14% |
| 2016 Q1 | 0.03 USD | 141.32% |
| 2016 Q4 | 0.00 USD | -86.67% |
| 2015 FY | - USD | -334.69% |
| 2015 Q4 | -0.07 USD | -12.91% |
| 2015 Q3 | -0.06 USD | 99.41% |
| 2015 Q2 | -10.96 USD | -33623.08% |
| 2015 Q1 | -0.03 USD | 82.89% |
| 2014 Q2 | -0.08 USD | 47.94% |
| 2014 Q3 | -0.06 USD | 28.21% |
| 2014 Q1 | -0.16 USD | 89.19% |
| 2014 Q4 | -0.19 USD | -217.73% |
| 2014 FY | - USD | 3.92% |
| 2013 Q3 | -1.48 USD | -6.47% |
| 2013 Q1 | -1.87 USD | 0.0% |
| 2013 Q2 | -1.39 USD | 25.67% |
| 2013 Q4 | -1.48 USD | 0.0% |
| 2013 FY | - USD | 94.76% |
| 2012 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Abbott Laboratories | 3.30 USD | 184.242% |
| Allurion Technologies Inc. | -2.31 USD | -20.346% |
| Artivion, Inc. | -0.75 USD | -270.667% |
| Avanos Medical, Inc. | -1.33 USD | -109.023% |
| Butterfly Network, Inc. | -0.65 USD | -327.692% |
| Butterfly Network, Inc. | -0.65 USD | -327.692% |
| Bio-Rad Laboratories, Inc. | -21.82 USD | 87.259% |
| Boston Scientific Corporation | 1.08 USD | 357.407% |
| Perspective Therapeutics, Inc. | -0.10 USD | -2680.0% |
| CONMED Corporation | 2.10 USD | 232.381% |
| Edwards Lifesciences Corporation | 2.31 USD | 220.346% |
| Paragon 28, Inc. | -0.58 USD | -379.31% |
| Globus Medical, Inc. | 1.09 USD | 355.046% |
| Inspire Medical Systems, Inc. | -0.72 USD | -286.111% |
| Integer Holdings Corporation | 2.72 USD | 202.206% |
| Medtronic plc | 2.77 USD | 200.361% |
| Nevro Corp. | -2.56 USD | -8.594% |
| Owlet, Inc. | -4.53 USD | 38.631% |
| Penumbra, Inc. | 2.37 USD | 217.3% |
| Vicarious Surgical Inc. | -0.49 USD | -467.347% |
| Smith & Nephew plc | 0.60 USD | 563.333% |
| Sonendo, Inc. | -0.65 USD | -327.692% |
| STERIS plc | 3.83 USD | 172.585% |
| Stryker Corporation | 8.34 USD | 133.333% |
| Vapotherm, Inc. | -9.64 USD | 71.162% |
| Zimmer Biomet Holdings, Inc. | 4.91 USD | 156.619% |